Molecular Diagnosis & Therapy welcomes current opinion articles on emerging or contentious issues, comprehensive narrative reviews, systematic reviews (as outlined by the PRISMA statement), original research articles (including short communications) and letters to the editor. All manuscripts are subject to peer review by international experts. 分子诊断与治疗学欢迎就新出现或有争议的问题发表当前的观点文章，全面 的叙事评论，系统的评论（如PRISMA声明所述），原创的研究文章（包括短 文）和致编辑的信。所有手稿均需接受国际专家的同行评审。。